For Healthcare Professionals

Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia


About the study

The current study is an exploratory, phase IIa randomized clinical trial (RCT) aiming to evaluate if early presepsin increase coupled with early initiation of anakinra as an adjunct therapy to the standard-of-care treatment may improve outcomes of community-acquired pneumonia or hospital-acquired pneumonia.

Who can take part

You may be eligible to participate in the study if you meet the following criteria:


Inclusion Criteria:

  1. Age equal to or above 18 years
  2. Male or female gender
  3. In case of women of reproductive age, willingness to use dual contraceptive method during the study period
  4. Written informed consent provided by the patient. For subjects without decision-making capacity, informed consent must be obtained from a legally designated representative following the national legislation in the Member State where the trial is planned
  5. Community-acquired pneumonia or hospital-acquired pneumonia
  6. qSOFA score equal to 1
  7. Serum presepsin > 350 pg/ml


Exclusion Criteria:

  1. Age below 18 years
  2. Denial of written informed consent
  3. Any stage IV malignancy
  4. Any do not resuscitate decision
  5. Patients with PaO2/FiO2 less than 150 necessitating non-invasive ventilation or mechanical ventilation
  6. Hospitalization in Intensive Care Unit
  7. Known hypersensitivity to anakinra
  8. Oral or IV intake of corticosteroids at a daily dose equal to or greater than 0.4 mg/kg prednisone for a period greater than the last 15 days
  9. qSOFA score 0, 2 or 3
  10. Any anti-cytokine biological treatment for the last one month
  11. Pregnancy or lactation. Women of child-bearing potential will be screened by a urine pregnancy test before inclusion in the study
  12. Participation in any other interventional trial
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply

Contact the study center to learn if this study is a good match for you.

Study’s details


Community-acquired Pneumonia,Hospital-acquired Pneumonia

Age (in years)



Phase 2

Participants needed


Est. Completion Date

Mar 6, 2025

Treatment type



Hellenic Institute for the Study of Sepsis identifier


Study number


Understanding Clinical Trials

Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?


Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.